Richard’s reviews: Bisphosphonates, breast cancer & confounding

From Richard’s review this week, we look at whether bisphosphonates can prevent breast cancer, and whether bivalirudin is actually any better than good old-fashioned heparin in patients with ACS undergoing percutaneous coronary intervention